Viewing Study NCT04915950

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 5:03 PM
Ignite Modification Date: 2026-01-24 @ 8:00 AM
Study NCT ID: NCT04915950
Status: TERMINATED
Last Update Posted: 2023-12-22
First Post: 2021-06-01
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: A Study to Assess the Effect of Oral Temanogrel on Digital Blood Flow in Adult Participants With Raynaud's Phenomenon Secondary to Systemic Sclerosis
Sponsor: Pfizer
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Raynaud's Phenomenon Secondary to Systemic Sclerosis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Raynaud's phenomenon View
None SSc-RP View
None Systemic sclerosis View
None SSc View
None Digital cold sensitivity View
None Digital blood flow View
None APD791 View
None Temanogrel View